Laman UtamaCRL • NYSE
add
Charles River Lbrtrs ntrntl Inc
$167.70
Selepas Waktu Dagangan:(0.00%)0.00
$167.70
Tutup: 5 Nov, 4:09:01 PTG GMT-5 · USD · NYSE · Penafian
Tutup sebelumnya
$177.85
Julat hari
$160.01 - $180.19
Julat tahun
$91.86 - $230.02
Permodalan pasaran
8.25B USD
Bilangan Purata
1.02J
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NYSE
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Jun 2025info | Perubahan T/T |
|---|---|---|
Hasil | 1.03B | 0.59% |
Perbelanjaan pengendalian | 211.51J | 8.67% |
Pendapatan bersih | 52.33J | -44.38% |
Margin untung bersih | 5.07 | -44.71% |
Pendapatan bagi setiap syer | 3.12 | 11.43% |
EBITDA | 327.04J | 26.18% |
Kadar cukai berkesan | 26.22% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Jun 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 182.82J | 2.01% |
Jumlah aset | 7.56B | -4.88% |
Jumlah liabiliti | 4.16B | -0.34% |
Jumlah ekuiti | 3.40B | — |
Syer tertunggak | 49.21J | — |
Harga kepada buku | 2.61 | — |
Pulangan pada aset | 5.68% | — |
Pulangan pada modal | 6.93% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Jun 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 52.33J | -44.38% |
Tunai daripada operasi | 204.60J | 5.72% |
Tunai daripada pelaburan | -37.34J | 39.65% |
Tunai daripada pembiayaan | -226.92J | 20.62% |
Perubahan bersih dalam tunai | -46.99J | 70.17% |
Aliran tunai bebas | 228.38J | 54.82% |
Perihal
Charles River Laboratories International, Inc. is an American pharmaceutical and biotechnology contract research organisation headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides preclinical and clinical laboratory services for the development of new drugs, vaccines, and medical devices. Its operations span at least 20 countries, offering research models, safety assessment, and manufacturing support services to pharmaceutical, biotechnology, and government clients.
Charles River Laboratories is considered one of the largest CROs globally, known for its role in toxicology studies, animal research models, and microbial testing services used in regulatory submissions to health authorities such as the U.S. Food and Drug Administration. The company has also been the subject of public scrutiny and regulatory attention over its use of laboratory animals, including dogs, primates, and horseshoe crabs.
As of 2024, the company employs over 20,000 people worldwide and is publicly traded on the New York Stock Exchange under the ticker symbol CRL. Wikipedia
Diasaskan
1947
Ibu pejabat
Tapak web
Pekerja
19,400